RCT to Analyze the Efficacy of a Spanish Healthcare ministRy Based In InTervention to Reduce Frailty Status in Prefrail Older Adults
Launched by COMPLEJO HOSPITALARIO UNIVERSITARIO DE ALBACETE · Aug 4, 2021
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a program designed to help older adults who are at risk of becoming frail, which means they may have less strength and energy to carry out daily activities. The program includes group exercise sessions and nutritional support, guided by trained professionals, to improve physical health and overall quality of life. Researchers want to see if this intervention can make a positive difference in the participants' frailty status after one year, as well as reduce hospital visits and improve their well-being.
To participate in the trial, individuals must be community-dwelling adults aged 70 or older, able to perform physical exercises, and have a certain level of mobility. However, those with serious heart conditions or other health issues that might prevent safe participation will not be eligible. If you join, you can expect to be part of a supportive group focused on improving health through exercise and nutrition, and you will be closely monitored throughout the study to track your progress.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Community-dwelling adults with age equal or greater than 70 years.
- • Barthel index \> 85
- • Gait speed \< 0.8 m/s OR frailty /prefrailty using the frailty phenotype
- • Ability to realize the physical exercise program
- • Capacity to understand the procedures and interventions of the trial
- • Capacity to understand and sign the informed consent
- Exclusion Criteria:
- • Major contraindications for exercise: Severe aortic valve stenosis, myocardial infarction in the previous 6 weeks, Venous thromboembolic disease in the previous 6 weeks.
- • Inability to conduct the physical tests of the trial
- • Inability to understand the procedures of the trial
- • Active solid organ or hematologic neoplasm other than basocellular skin neoplasm, or life expectancy lower than one year.
- • Surgical intervention programmed that could interfere with the physical exercise program.
About Complejo Hospitalario Universitario De Albacete
The Complejo Hospitalario Universitario de Albacete is a prominent healthcare institution in Spain, dedicated to providing high-quality medical care and advancing clinical research. As a university hospital, it integrates comprehensive patient services with academic training and research initiatives, fostering innovation in medical practices. The institution is committed to enhancing health outcomes through rigorous clinical trials that explore new therapies and treatment methodologies, thereby contributing to the broader medical community and improving patient care standards. With a multidisciplinary team of healthcare professionals, the hospital plays a pivotal role in advancing medical knowledge and ensuring evidence-based practices within the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Albacete, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials